|
| View:
Latest News | Top Stories |
|
| Tuesday, Nov 3, 2009 |
|
| · | ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2009 and to Provide a Business Update
PR Newswire -
Tue Nov 3 |
|
| · | InSite Vision to Report Financial Results for the Third Quarter on November 11, 2009
Business Wire -
Tue Nov 3 |
|
| Monday, Nov 2, 2009 |
|
| · | Interim Study Data Demonstrate Eligen® B12 Oral Formulation Achieves Comparable Results to B12 Injection
Business Wire -
Mon Nov 2 |
|
| · | Bio-Path Holdings, Inc. Operations Update
Business Wire -
Mon Nov 2 |
|
| · | Generex's Glucose RapidSpray(TM) Featured on Doggie Chronicles Radio
GlobeNewswire -
Mon Nov 2 |
|
| · | PetMed Express D/B/A 1-800-PetMeds Announces Its Quarterly Dividend
GlobeNewswire -
Mon Nov 2 |
|
| Friday, Oct 30, 2009 |
|
| · | Penwest Third Quarter 2009 Financial Results Conference Call
GlobeNewswire -
Fri Oct 30 |
|
| Thursday, Oct 29, 2009 |
|
| · | Generex Announces That It Will Not Exercise Its Rights to Issue and Sell Stock Under Its At Market Issuance Sales Agreement With WM Smith Until Further Notice
GlobeNewswire -
Thu Oct 29 |
|
| · | Nektar to Announce Financial Results for the Third Quarter of 2009 on Wednesday, November 4, 2009, After Close of U.S.-Based Financial Markets
PR Newswire -
Thu Oct 29 |
|
| · | Elan Corporation Plc Announces Expiration of Tender Offer for 7¾% Senior Fixed Rate Notes Due 2011
Business Wire -
Thu Oct 29 |
|
| · | Alkermes to Host Conference Call to Discuss Financial Results for Second Quarter of Fiscal 2010
Business Wire -
Thu Oct 29 |
|
| · | Healthcare Industry Celebrates 25 Years of Advanced Pain Management With PCA Infusion System
PR Newswire -
Thu Oct 29 |
|
| Wednesday, Oct 28, 2009 |
|
| · | Columbia Laboratories Closes Registered Direct Common Stock and Warrant Offering
Business Wire -
Wed Oct 28 |
|
| · | Penwest Formulation Demonstrates Proof-of-Principal in Phase I Trial in Development Program With Otsuka Pharmaceutical
GlobeNewswire -
Wed Oct 28 |
|
| · | Nektar Completes Enrollment Ahead of Schedule in Phase 2 Clinical Trial Evaluating NKTR-102 in Patients with Platinum-Resistant Ovarian Cancer
PR Newswire -
Wed Oct 28 |
|
| Tuesday, Oct 27, 2009 |
|
| · | Subset Data from Two Randomized Phase 3 Trials Show TYSABRI Significantly Reduces Rates of Hospitalization in Patients with Moderate-to-Severe Crohn's Disease
Business Wire -
Tue Oct 27 |
|
| · | NovaDel Licenses its NitroMist® Lingual Spray to Mist
Business Wire -
Tue Oct 27 |
|
| · | Hospira, Inc. Q3 2009 Earnings Call Transcript
at Seeking Alpha -
Tue Oct 27 |
|
| · | Matrixx Initiatives, Inc. F2Q10 (Qtr End 09/30/09) Earnings Call Transcript
at Seeking Alpha -
Tue Oct 27 |
|
| · | Hospira Surges Ahead
Zacks.com -
Tue Oct 27 |
|
|
More Latest News...
|
